APHP, GHU Paris-Est, DMU BIO-GEM, Laboratoire de Bactériologie, Paris, France.
INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, CIMI-Paris, Paris, France.
J Clin Microbiol. 2021 May 19;59(6). doi: 10.1128/JCM.02973-20.
The increasing incidence of carbapenemase-producing Gram-negative bacilli (C-PGNB) represents a major public health challenge. Rapid detection of digestive colonization with C-PGNB is fundamental to control their spread. We performed the validation of a rapid protocol for C-PGNB detection directly on rectal swabs. We developed a protocol combining enrichment by a rapid selective subculture of the rectal swab medium and realization of a Resist-4 O.K.N.V. K-SeT test on the bacterial pellet obtained. The limit of detection and performances of this protocol were validated on 52 C-PGNB strains spiked on a calibrated sample suspension and confirmed in clinical settings on 144 rectal swabs sampled from patients with C-PGNB digestive colonization ( = 48) and controls (patients with extended-spectrum beta-lactamase [ESBL] colonization [ = 48] and without carbapenemase/ESBL [ = 48]). The protocol detected, with 100% sensitivity, the presence of the 15 OXA-48-, 14 KPC-, 13 NDM-, and 10 VIM-producing GNB from 10 CFU/ml. The limit of detection was 2 × 10 CFU/ml. Among the 48 C-PGNB-containing rectal swabs of the validation cohort, 46 were accurately detected. False negative were observed for 1 NDM-producing strain and 1 OXA-48-producing strain. The 96 control swabs were negative. Sensitivity and specificity for C-PGNB detection were 97.7% (95% confidence interval [CI], 87.7 to 100) and 100% (95% CI, 96.2 to 100). The negative likelihood ratio was 0.04 (95% CI, 0.01 to 0.16). Considering a C-PGNB digestive colonization prevalence between 0.01% and 0.1%, positive and negative predictive values were 100%. Our protocol is a rapid and low-cost method detecting accurately the digestive colonization with carbapenemase-producing in 4 h without any requirement for specific equipment.
产碳青霉烯酶革兰氏阴性菌(C-PGNB)的发病率不断上升,这是一个主要的公共卫生挑战。快速检测消化定植的 C-PGNB 对于控制其传播至关重要。我们验证了一种直接从直肠拭子上检测 C-PGNB 的快速检测方案。我们开发了一种方案,该方案结合了直肠拭子培养基的快速选择性亚培养富集和从获得的细菌沉淀上进行 Resist-4 O.K.N.V. K-SeT 测试。该方案的检测限和性能在 52 株 C-PGNB 菌株上进行了验证,这些菌株在经过校准的样本悬浮液中进行了接种,并在临床环境中对 144 例消化定植 C-PGNB( = 48)和对照组(定植扩展谱β-内酰胺酶 [ESBL]的患者 [ = 48] 和无碳青霉烯酶/ESBL 的患者 [ = 48])的直肠拭子进行了确认。该方案以 100%的灵敏度检测到 15 株 OXA-48-、14 株 KPC-、13 株 NDM-和 10 株 VIM 产 GNB 从 10 CFU/ml。检测限为 2 × 10 CFU/ml。在验证队列中,48 例含 C-PGNB 的直肠拭子中,46 例得到准确检测。1 株 NDM 产菌株和 1 株 OXA-48 产菌株出现假阴性。96 例对照拭子均为阴性。C-PGNB 检测的敏感性和特异性分别为 97.7%(95%置信区间 [CI],87.7%至 100%)和 100%(95%CI,96.2%至 100%)。阴性似然比为 0.04(95%CI,0.01 至 0.16)。考虑到 C-PGNB 消化定植率在 0.01%至 0.1%之间,阳性和阴性预测值均为 100%。我们的方案是一种快速且低成本的方法,可在 4 小时内准确检测产碳青霉烯酶菌的消化定植,无需任何特殊设备。